I investigate the contribution of pharmaceutical innovation to recent longevity growth in Germany and France. First, I …-adjusted mortality rates of residents of Germany, using longitudinal, annual, state-level data during the period 2000-2007. The estimates …-2006. The estimates imply that chemotherapy innovation accounted for at least one-sixth of the decline in French cancer …

may even reduce welfare. The reason is that it crowds out proprietary innovation which on net may reduce total innovation … in the long run. These effects would be reinforced if philanthropical innovation diverted people from other productive …

on panel data for West Germany indicate that the legal change did have a negative effect on severance pay. -- panel data …

the question whether the omission of important control variables in matching estimation leads to biased impact estimates …

the question whether the omission of important control variables in matching estimation leads to biased impact estimates … as detailed regional characteristics are also relevant. -- training ; job search assistance ; matching estimation …